• Mashup Score: 0

    Host Eugene Borukhovich explores how non-molecular therapies and interventions can prevent, manage or even cure diseases. Learn about the rapidly evolving field of Digital Therapeutics, its history, the evolving regulatory and reimbursement frameworks, and the trailblazers creating and advancing

    Tweet Tweets with this article
    • Ready to learn about the global non-profit thats the professional home for members of the #digitalmedicine community? Tune into the latest DTx Replay with @HealthEugene and Jennifer Goldsack, CEO of @_DiMeSociety Listen now: https://t.co/MrPa5KUQTL #digitaltherapeutics #dtx https://t.co/FLevOLmoRc

  • Mashup Score: 4

    As the use of artificial intelligence and machine learning (AI/ML) continues to expand in healthcare, much attention has been given to mitigating bias in algorithms to ensure they are employed fairly and transparently. Less attention has fallen to addressing potential bias among AI/ML’s human users or factors that influence user reliance. We argue for a systematic approach to identifying the…

    Tweet Tweets with this article
    • .@Nature #DigitalMedicine: New article cautions that before #AI tools are “released into the wild,” we must better understand their outcomes & impacts in the hands of imperfect human users. Systematic approach needed for tackling the challenge. #decision https://t.co/WVidQFKnM3 https://t.co/l05xruvIDJ

  • Mashup Score: 2

    Matt Franklin, Akili Interactive’s president and COO, explains the company’s strategy for launching EndeavorRx, its video game digital therapeutic for children with ADHD.

    Tweet Tweets with this article
    • Delighted to see the #digiceutical (aka #pDTx or #digitalmedicine) company @AkiliLabs go public recently. Mice article in which @MobiHealthNews interviews Akili's CEO on his strategy for getting the product to market #digitalhealth https://t.co/ZnpzbGNuPr